Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 1-2, 2002, Pages 313-318

  Malmberg Aiello, Petra ^a   Ipponi, Alessandra ^a   Bartolini, Alessandro ^a   Schunack, Walter ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

2 (3 Trifluoromethylphenyl)histamine; Anxiety; Histamine H1 receptor agonist; Histamine H1 receptor antagonist; Histamine H1 receptors; Impromidine; Light dark box test; Metoprine; Pyrilamine; Thioperamide

Indexed keywords

2 (3 TRIFLUOROMETHYLPHENYL)HISTAMINE; DIAZEPAM; ENZYME INHIBITOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR AGONIST; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE METHYLTRANSFERASE; IMPROMIDINE; MEPYRAMINE; METODICLOROFEN; POSTSYNAPTIC RECEPTOR; THIOPERAMIDE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; HISTAMINE AGONIST; PIPERIDINE DERIVATIVE; PYRIMETHAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; TRANQUILIZING ACTIVITY; ANIMAL; CHEMICALLY INDUCED DISORDER; DARKNESS; HISTAMINE RELEASE; LIGHT; METABOLISM; PHYSIOLOGY;

ANIMALS; ANXIETY; DARKNESS; HISTAMINE AGONISTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; LIGHT; MALE; MICE; PIPERIDINES; PYRIMETHAMINE; RECEPTORS, HISTAMINE H1;

EID: 0036364897     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-3057(01)00691-8     Document Type: Article

References (33)

1. 3-receptors
2. 3 receptor: Characterization and autoradiographic localization in rat brain
3. Elevation of brain histamine levels by diaminopyrimidine inhibitors of histamine N-methyltransferase
4. Inhibition of histamine-metabolizing enzymes and elevation of histamine levels in tissues by lipid-soluble anticancer folate antagonists
5. Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region
6. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
7. Intraventricular infusion of the histamine H1 receptor antagonist chlorpheniramine improves maze performance and has anxiolytic-like effects in aged hybrid Fischer 344Xbrown Norway rats
8. Distribution, properties and functional characteristics of three classes of histamine receptor
9. Inhibition of brain histamine metabolism by metoprine
10. 3-receptor antagonist, in a light/dark test measuring anxiety in mice
11. Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice
12. Effects of the acute and chronic restraint stresses on the central histaminergic neuron system of Fischer rat
13. Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis
14. Investigation into the role of histamine receptors in rodent antinociception
15. 1 receptor agonists in the mouse forced swim test
16. Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice
17. 1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines and analogues
18. Role of histamine in rodent antinociception
19. 1 receptor activation in rodents
20. 1 receptor agonists in a modified mouse passive avoidance test
21. Anxiogenic-like effects of metoprine, thioperamide and 2-(3-trifluoromethylphenyl) histamine during the mouse light/dark box test
22. Effect of stress on brain histamine
23. Diazepam-induced decrease in histamine turnover in mouse brain
24. 3 receptor ligands in experimental models of anxiety and depression
25. 3 receptors in rat brain areas
26. Histaminergic neurons facilitate social memory in rats
27. 2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes
28. Central histaminergic involvement during stress in rats
29. v mice
30. 3-receptor
31. Synthesis, benzodiazepine receptor affinity and in vivo testing of 3-aryl-4,7-dihydro-6-(N1′-alkyl pyrazol-3′- or 5′-yl)pyrazolo[1,5-a]pyrimidin-7-ones
32. 1 receptors
33. A fully automated light/dark apparatus useful for comparing anxiolytic agents